phenylalanine has been researched along with Dyslipidemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SS; Koide, M; Nagasawa, Y; Sawada, T; Shiotani, H; Terashita, D; Yokoyama, M | 1 |
| Bao, Y; Deng, Z; Jia, W; Li, H; Lu, J; Mo, Y; Peng, Y; Zhang, X; Zhou, J | 1 |
2 trial(s) available for phenylalanine and Dyslipidemia
| Article | Year |
|---|---|
Comparison of effects of α-Glucosidase inhibitors and glinide drugs on endothelial dysfunction in diabetic patients with coronary artery disease.
Topics: 1-Deoxynojirimycin; Aged; Aged, 80 and over; Coronary Artery Disease; Cyclohexanes; Diabetic Angiopathies; Dyslipidemias; Endothelium, Vascular; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Nateglinide; Phenylalanine | 2014 |
Differential therapeutic effects of nateglinide and acarbose on fasting and postprandial lipid profiles: a randomized trial.
Topics: Acarbose; Adult; China; Cholesterol, HDL; Cholesterol, LDL; Cyclohexanes; Diabetes Mellitus, Type 2; Dyslipidemias; Fasting; Female; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Nateglinide; Phenylalanine; Postprandial Period; Prospective Studies; Time Factors; Triglycerides | 2015 |